Telmisartan Tablets

Posted Date: Mar 27, 2025
Feb 28, 2025
Awarded Date: No Awarded Date
SetAside Type
Solicitation ID Solicitation Title Solicitation Office
SPE2E2-24-R-0015 Telmisartan Tablets
Synopsis

Amendment 0004 has been made to accomdate for solicitation changes pursuant to the authority of CD 2025-O0003 and CD 2025-O0004.

.... Read More
Office Location Agency Name Solicitation Base Posting Type
DEFENSE LOGISTICS AGENCY Combined Synopsis/Solicitation
SetAside Type
Solicitation ID Solicitation Title Solicitation Office
SPE2E2-24-R-0015 Telmisartan Tablets
Synopsis

Amendment 0003 has been issued to allow for e-mail submission on this solicitaiton. 

.... Read More
Office Location Agency Name Solicitation Base Posting Type
DEFENSE LOGISTICS AGENCY Combined Synopsis/Solicitation
SetAside Type
Solicitation ID Solicitation Title Solicitation Office
SPE2E2-24-R-0015 Telmisartan Tablets
Synopsis

Amendment 0002 has been issued to extend the solicitation closing date to February 28, 2025 3:00 PM EST.

.... Read More
Office Location Agency Name Solicitation Base Posting Type
DEFENSE LOGISTICS AGENCY Combined Synopsis/Solicitation
SetAside Type
Solicitation ID Solicitation Title Solicitation Office
SPE2E2-24-R-0015 Telmisartan Tablets
Synopsis

Amendment 0001 has been issued to extend the solicitation closing date to February 21, 2025 3:00 PM EST.

.... Read More
Office Location Agency Name Solicitation Base Posting Type
DEFENSE LOGISTICS AGENCY Combined Synopsis/Solicitation
SetAside Type
Solicitation ID Solicitation Title Solicitation Office
SPE2E2-24-R-0015 Telmisartan Tablets
Synopsis

Solicitation Attached.

.... Read More
Office Location Agency Name Solicitation Base Posting Type
DEFENSE LOGISTICS AGENCY Combined Synopsis/Solicitation
An error has occurred. This application may no longer respond until reloaded. Reload 🗙